Simon Quick Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-911
Closed -$205K 433
2026
Q1
$205K Buy
911
+4
+0.4% +$997 0.01% 366
2025
Q4
$218K Buy
907
+25
+3% +$6.39K 0.01% 365
2025
Q3
$241K Buy
+882
New +$241K 0.01% 361
2025
Q2
Sell
-1,951
Closed -$437K 591
2025
Q1
$437K Buy
1,951
+302
+18% +$70.5K 0.02% 328
2024
Q4
$377K Buy
1,649
+136
+9% +$32.7K 0.02% 306
2024
Q3
$369K Buy
1,513
+169
+13% +$37.8K 0.02% 277
2024
Q2
$257K Buy
1,344
+14
+1% +$2.84K 0.02% 312
2024
Q1
$263K Buy
1,330
+97
+8% +$17.8K 0.02% 330
2023
Q4
$212K Buy
+1,233
New +$189K 0.02% 306
2022
Q2
Sell
-2
Closed 347
2022
Q1
$0 Sell
2
-447
-100% -$108K ﹤0.01% 365
2021
Q4
$117K Buy
449
+444
+8,880% +$115K 0.03% 145
2021
Q3
$1K Sell
5
-215
-98% -$58.8K ﹤0.01% 410
2021
Q2
$54K Hold
220
0.01% 237
2021
Q1
$42K Hold
220
0.01% 284
2020
Q4
$47K Buy
+220
New +$43.9K 0.01% 236
2020
Q1
Sell
-11
Closed -$2K 668
2019
Q4
$2K Buy
+11
New +$1.58K ﹤0.01% 619

Other funds holding RMD

Simon Quick Advisors's RMD Position: Q2 2026 in Review

Simon Quick Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 911 shares — an estimated $205K sold.

Simon Quick Advisors first reported a position in RMD in Q4 2019 and held it in 16 quarters. The position peaked at $437K in Q1 2025. 880 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Simon Quick Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • Simon Quick Advisors sold 911 ResMed shares in Q2 2026, an estimated $205K.
  • Simon Quick Advisors first reported a position in ResMed in Q4 2019 and held it in 16 quarters.
  • Simon Quick Advisors's ResMed position peaked at $437K in Q1 2025.
  • 880 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Simon Quick Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.